The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis
Hong Shen,Rui Min,Qi Tan,Weiping Xie,Hong Wang,Hongqiu Pan+4 more-2015-01-01-Archives of Medical Science
22PDF
TL;DRAbstract
Exogenous IL-2 in the present regimen improves immunity status. Adjunctive immunotherapy with a long period of rhIL-2 is a promising treatment modality for MDR-TB.
Chat with Paper
AI Agents for this Paper
Exogenous IL-2 in the present regimen improves immunity status. Adjunctive immunotherapy with a long period of rhIL-2 is a promising treatment modality for MDR-TB.
Keywords
MedicineTuberculosisRegimenInternal medicineImmunotherapyChemotherapyAdjunctive treatmentMultiple drug resistance
Chat
Click to start Chat